Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the koko-analytics domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /hum/web/sitestest.hum.uu.nl/htdocs/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the formidable domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /hum/web/sitestest.hum.uu.nl/htdocs/wp-includes/functions.php on line 6114
CARTHAGO ITN | AO Foundation (ARI)

CARTHAGO ITN

AO Foundation (ARI)

The AO Foundation is a medically guided, global network of surgeons. It is the world’s leading education and research organization for trauma and musculoskeletal treatment. Within the AO Research Institute Davos, the Regenerative Orthopaedics Program has established research activities in the field of bone, cartilage, and intervertebral disc regeneration, with a major focus on regenerative medicine and tissue engineering. Extended research experience with specific bioreactor systems for cartilage and disc will considerably contribute to the ex vivo component of the overall project.

Martin Stoddart is full Professor, Program Leader and Principal Scientist. At AO he is the Stem Cell focus area leader, with expertise in cartilage cell biology, biochemistry, stem cell differentiation, gene therapy, in vitro models, bioreactors and mechanobiology. Sibylle Grad, is Principal Scientist, and disc/Cartilage focus area leader, with expertise in IVD and cartilage biology, biochemistry, tissue engineering, regeneration, biomarkers, in vitro models and bioreactors.

ARI will use their advanced bioreactor-based test systems for verification of the efficiency of the nucleic acid carriers and ultrasound protocols in modulating gene expression in tissue residing cells.